NCT05882500

Brief Summary

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2011

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2016

Completed
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 31, 2023

Completed
Last Updated

May 31, 2023

Status Verified

May 1, 2023

Enrollment Period

5.6 years

First QC Date

May 11, 2023

Last Update Submit

May 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Se-osteopontin

    Se-osteopontin will be measured at admission and on day 2 and 3 of hospital stay. The change over time will be correlated to severety of pancreatitis as classified in the current Atlanta classification.

    Within 3 days from diagnosis

Study Arms (1)

Pancreatits

Patients with pancreatitis based ont the Atlanta criteria

Other: No intervention, observation

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with diagnosis of pancreatitis

You may qualify if:

  • Diagnosis of pancreatitis

You may not qualify if:

  • Pregnancy, lactation, unable to understand the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linkoping University Hospital

Linköping, 582 72, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum

MeSH Terms

Conditions

Pancreatitis

Interventions

Observation

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 11, 2023

First Posted

May 31, 2023

Study Start

March 3, 2011

Primary Completion

October 19, 2016

Study Completion

January 31, 2023

Last Updated

May 31, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations